GetTopicDetailResponse(id=6ba655658cc, topicName=抗腫瘤血管生成, introduction=抗腫瘤血管生成, content=null, image=null, comments=2, allHits=1216, url=https://h5.medsci.cn/topic?id=55658, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=5041, tagList=[TagDto(tagId=5041, tagName=抗腫瘤血管生成)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2236248, encodeId=8efb22362488b, content=<a href='/topic/show?id=6ba655658cc' target=_blank style='color:#2F92EE;'>#抗腫瘤血管生成#</a> <a href='/topic/show?id=b9bf55e735a' target=_blank style='color:#2F92EE;'>#抗血管生成治療#</a>, objectTitle=腫瘤的血管生成信號通路與抗血管生成治療, objectType=article, longId=796061, objectId=54b5e960611b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241105/1730803169148_8538692.jpg, objectUrl=/article/show_article.do?id=54b5e960611b, replyNumber=0, likeNumber=52, createdTime=2024-11-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=54b5e960611b, moduleTitle=腫瘤的血管生成信號通路與抗血管生成治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=54b5e960611b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2061055, encodeId=88f1206105561, content=<a href='/topic/show?id=6ba655658cc' target=_blank style='color:#2F92EE;'>#抗腫瘤血管生成#</a>, objectTitle=PLoS One.：腫瘤T1弛豫時間可評估貝伐單抗抗腫瘤血管生成療法的反應, objectType=article, longId=52555, objectId=adfe525550c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adfe525550c, replyNumber=0, likeNumber=85, createdTime=2016-05-25, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adfe525550c, moduleTitle=PLoS One.：腫瘤T1弛豫時間可評估貝伐單抗抗腫瘤血管生成療法的反應, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=adfe525550c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061054, encodeId=10ce206105494, content=<a href='/topic/show?id=6ba655658cc' target=_blank style='color:#2F92EE;'>#抗腫瘤血管生成#</a>, objectTitle=抗腫瘤血管生成可能是腦膠質瘤治療途徑之一, objectType=article, longId=21751, objectId=075421e5129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=075421e5129, replyNumber=0, likeNumber=99, createdTime=2013-09-06, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=075421e5129, moduleTitle=抗腫瘤血管生成可能是腦膠質瘤治療途徑之一, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=075421e5129)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
